On various human cells, such as B lymphocytes, phagocytes, and erythrocytes, binding structures or receptors exist for interaction with sites of the C3 molecule and its fragments C3b, iC3b, and C3d (see reference 6 for a review). We accidentally observed that yeast cells contaminating a lymphoblastoid culture reacted with complement-coated sheep erythrocytes (EAC) in a similar way as lymphoblasts. This was surprising to us, because the cell wall of yeasts has a structure very different from that of the lipoprotein membrane of mammalian cells (2, 7) . It consists mainly of a skeleton of 3-glucan molecules in which mannan, in linkage to cell wall proteins, plays the role of a cementous substance (10) . Thus, so-called mannoproteins are formed, which are typical glycoproteins of well-defined structure (1, 11) .
Since yeasts are frequently encountered pathogens, we wanted to define their complement-dependent reaction more precisely and chose Candida albicans for investigation, since it is the most common cause of yeast infections in humans. C. albicans was compared with less pathogenic Candida species.
For the experiments reported below, trypsin from bovine pancreas (40 U/mg), trypsin inhibitor from soybean (35 U/mg), mannan from bakers' yeast, D-glucose, D-galactose, N-acetylglucosamine, and D-mannose were bought from Serva, Heidelberg, Federal Republic of Germany; Lmannose was from EGA-Chemie, Steinheim, Federal Republic of Germany; and bovine serum albumin, L-lysine hydrochloride, and glutaraldehyde (20%) were from Sigma Chemical Co., Munich, Federal Republic of Germany. Phosphate-buffered saline (PBS), veronal-buffered saline, veronal-buffered saline containing sucrose, and veronalbuffered saline containing EDTA were composed as previously described (5, 14) .
The first component of complement (Cl) was prepared from guinea pig serum (4) , and all other complement components (C2, C4, and C3), factor H (ff1H protein), and factor I (C3b-inactivator protein) were isolated from human serum as previously described (14 We tried to produce inhibition of the adherence effect by preincubating the various cells in different reagents (equal volumes of 100 ,ul) at 37°C. Further treatment of cells varied. Evaluation was similar to that of the adherence test. However, special notice was given to the microscopic formation of the cell complexes that showed binding of erythrocytes (i.e., number of erythrocytes and number of areas binding erythrocytes).
In preliminary experiments with glutaraldehyde-fixed EAC, it could be demonstrated that complement-dependent adherence to C. albicans cells grown in glucose broth, RPMI 1640, and RPMI 1640 containing 5% fetal calf serum occurred qualitatively equally. Quantitative results varied because of different growth characteristics in the different media.
To identify the complement component that was responsible for adherence, we studied complement intermediates (EA coated with purified C4, C2, C3b, C3b-H, and iC3b or C3d or both) with the test systems described above. Results are shown in Table 1 and Fig. 1 To rule out restriction of the adherence effect to our initial test strain, we tested another strain and the two serotypes of C. albicans and four other Candida species for adherence of iC3b and C3d intermediates. All samples of C. albicans and C. stellatoidea showed qualitatively equivalent adherence. C. tropicalis, C. parapsilosis, and C. krusei did not bind iC3b and C3d intermediates. Apparently, adherence effectively . . . . ___.
-r--*_ Thus, we could demonstrate that iC3b-and C3d-coated particles bound to the C. albicans cell surface very intensively. Neither a particular growth factor nor fetal serum contained in the medium was necessary for this effect.
From studies performed to characterize the nature of the interaction, there was evidence that the monosaccharides D-glucose and D-mannose could inhibit interaction between iC3b or C3d and C. albicans. This suggested a lectinlike nature of the possible interaction between iC3b or C3d and the mannoproteins on the Candida cell wall. Comparable results were found for complement-dependent binding to human erythrocytes (13) .
Examination of different C. albicans strains and serotypes revealed no restriction of reactivity. However, among the different Candida species only C. stellatoidea, in addition to C. albicans, was able to bind iC3b and C3d. C. stellatoidea is very closely related to C. albicans. Both species form an immunogenically highly active group compared with C. tropicalis and other species (9) . This is consistent with observations of the pathogenicity of the different species.
It remains unclear which sites in the iC3b and C3d molecules mediated the interaction. Certainly the sites are different from the metastable binding site of C3 (12) , which attaches C3b covalently to acceptors on the Candida cell surface or to sensitized erythrocytes as used in the adherence assay.
Speculating on a possible meaning of this iC3b-and C3d-dependent effect in vivo, one is led by the restriction of interaction to highly pathogenic Candida species to suppose a role of iC3b or C3d binding in the pathogenetic mechanism. In human serum, Candida cells show a tendency to clump (3, 8; 
